BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 21545554)

  • 1. The availability, diversion and injection of pharmaceutical opioids in South Asia.
    Larance B; Ambekar A; Azim T; Murthy P; Panda S; Degenhardt L; Mathers B
    Drug Alcohol Rev; 2011 May; 30(3):246-54. PubMed ID: 21545554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non-adherence and aberrant medication-related behaviours.
    Larance B; Degenhardt L; Lintzeris N; Winstock A; Mattick R
    Drug Alcohol Rev; 2011 May; 30(3):236-45. PubMed ID: 21545553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids.
    Peacock A; Bruno R; Cama E; Kihas I; Larance B; Lintzeris N; Hordern A; White N; Ali R; Degenhardt L
    Drug Alcohol Rev; 2015 Nov; 34(6):611-22. PubMed ID: 26084592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type of opioids injected: does it matter? A multicentric cross-sectional study of people who inject drugs.
    Ambekar A; Rao R; Mishra AK; Agrawal A
    Drug Alcohol Rev; 2015 Jan; 34(1):97-104. PubMed ID: 25302827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
    Winstock AR; Lea T; Sheridan J
    Int J Drug Policy; 2008 Dec; 19(6):450-8. PubMed ID: 18359216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing the benefits and reducing the harms of prescription opioid analgesics.
    Hallinan R; Osborn M; Cohen M; Dobbin M; Wodak A
    Drug Alcohol Rev; 2011 May; 30(3):315-23. PubMed ID: 21545563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
    Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
    Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine drug testing in chronic pain.
    Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J
    Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioids in the management of HIV-related pain.
    Krashin DL; Merrill JO; Trescot AM
    Pain Physician; 2012 Jul; 15(3 Suppl):ES157-68. PubMed ID: 22786454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foundations of opioid risk management.
    Katz NP; Adams EH; Benneyan JC; Birnbaum HG; Budman SH; Buzzeo RW; Carr DB; Cicero TJ; Gourlay D; Inciardi JA; Joranson DE; Kesslick J; Lande SD
    Clin J Pain; 2007 Feb; 23(2):103-18. PubMed ID: 17237659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burden of the nonmedical use of prescription opioid analgesics.
    Gilson AM; Kreis PG
    Pain Med; 2009 Jul; 10 Suppl 2():S89-100. PubMed ID: 19691688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated magnitude of diversion and abuse of opioids relative to benzodiazepines in France.
    Pauly V; Pradel V; Pourcel L; Nordmann S; Frauger E; Lapeyre-Mestre M; Micallef J; Thirion X
    Drug Alcohol Depend; 2012 Nov; 126(1-2):13-20. PubMed ID: 22475815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring opioid adherence in chronic pain patients: assessment of risk of substance misuse.
    Solanki DR; Koyyalagunta D; Shah RV; Silverman SM; Manchikanti L
    Pain Physician; 2011; 14(2):E119-31. PubMed ID: 21412377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the proportion of prescription opioids that is consumed by people who inject drugs in Australia.
    Degenhardt L; Gilmour S; Shand F; Bruno R; Campbell G; Mattick RP; Larance B; Hall W
    Drug Alcohol Rev; 2013 Sep; 32(5):468-74. PubMed ID: 23889303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to optimize pain management with opioids while minimizing risk of abuse.
    Brennan MJ; Stanos S
    PM R; 2010 Jun; 2(6):544-58. PubMed ID: 20630441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The global diversion of pharmaceutical drugs: opiate treatment and the diversion of pharmaceutical opiates: a clinician's perspective.
    Bell J
    Addiction; 2010 Sep; 105(9):1531-7. PubMed ID: 20626373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.
    Trescot AM; Helm S; Hansen H; Benyamin R; Glaser SE; Adlaka R; Patel S; Manchikanti L
    Pain Physician; 2008 Mar; 11(2 Suppl):S5-S62. PubMed ID: 18443640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use and abuse of opioid analgesics: potential methods to prevent and deter non-medical consumption of prescription opioids.
    Woolf CJ; Hashmi M
    Curr Opin Investig Drugs; 2004 Jan; 5(1):61-6. PubMed ID: 14983975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent analgesics are more expensive for patients in developing countries: a comparative study.
    De Lima L; Sweeney C; Palmer JL; Bruera E
    J Pain Palliat Care Pharmacother; 2004; 18(1):59-70. PubMed ID: 15148009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.